{"entity":{"type":"insider","cik":"0001568249","url":"/insider/0001568249","json_url":"/insider/0001568249.json","name":"Rhodes Jennifer J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":27,"first":"2014-01-23","last":"2026-03-26","span_basis":"filed_date"},"name_variants":[{"name":"Rhodes Jennifer J","source":"filing","n_filings":27,"first_seen":"2014-01-23","last_seen":"2026-03-26"}],"transactions":[{"id":6094072,"accession":"0001568249-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001568249-26-000005","line_url":"/filing/0001568249-26-000005#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (EVP, CHIEF LEGAL OFFICER, SEC)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF LEGAL OFFICER, SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3844.0,"shares_display":"3,844","price_per_share":21.47,"price_display":"21.47","price_state":"stated","total_value":82530.68,"total_display":"82,530.68","total_whole":"82,531","shares_owned_after":11280.0,"shares_owned_after_display":"11,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-26","scope":"insider"},{"id":6213246,"accession":"0001568249-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001568249-26-000002","line_url":"/filing/0001568249-26-000002#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (EVP, CHIEF LEGAL OFFICER, SEC)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF LEGAL OFFICER, SEC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF LEGAL OFFICER, SEC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6950.0,"shares_display":"6,950","price_per_share":23.38,"price_display":"23.38","price_state":"stated","total_value":162491.0,"total_display":"162,491.00","total_whole":"162,491","shares_owned_after":7609.0,"shares_owned_after_display":"7,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-10","scope":"insider"},{"id":4531440,"accession":"0001601485-21-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000083","line_url":"/filing/0001601485-21-000083#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":451.0,"shares_display":"451","price_per_share":2.4171,"price_display":"2.42","price_state":"stated","total_value":1090.1121,"total_display":"1,090.11","total_whole":"1,090","shares_owned_after":30399.0,"shares_owned_after_display":"30,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-15","scope":"insider"},{"id":4431703,"accession":"0001601485-21-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000072","line_url":"/filing/0001601485-21-000072#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":433.0,"shares_display":"433","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":1905.2,"total_display":"1,905.20","total_whole":"1,905","shares_owned_after":30850.0,"shares_owned_after_display":"30,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-16","scope":"insider"},{"id":4738375,"accession":"0001601485-21-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000060","line_url":"/filing/0001601485-21-000060#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430.0,"shares_display":"430","price_per_share":8.65,"price_display":"8.65","price_state":"stated","total_value":3719.5,"total_display":"3,719.50","total_whole":"3,720","shares_owned_after":31283.0,"shares_owned_after_display":"31,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-15","scope":"insider"},{"id":4431692,"accession":"0001601485-21-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000056","line_url":"/filing/0001601485-21-000056#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430.0,"shares_display":"430","price_per_share":10.64,"price_display":"10.64","price_state":"stated","total_value":4575.2,"total_display":"4,575.20","total_whole":"4,575","shares_owned_after":31713.0,"shares_owned_after_display":"31,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-15","scope":"insider"},{"id":4391854,"accession":"0001601485-21-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000050","line_url":"/filing/0001601485-21-000050#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":445.0,"shares_display":"445","price_per_share":10.68,"price_display":"10.68","price_state":"stated","total_value":4752.6,"total_display":"4,752.60","total_whole":"4,753","shares_owned_after":32143.0,"shares_owned_after_display":"32,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider"},{"id":4700897,"accession":"0001601485-21-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000040","line_url":"/filing/0001601485-21-000040#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":432.0,"shares_display":"432","price_per_share":10.94,"price_display":"10.94","price_state":"stated","total_value":4726.08,"total_display":"4,726.08","total_whole":"4,726","shares_owned_after":32588.0,"shares_owned_after_display":"32,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-22","scope":"insider"},{"id":4333241,"accession":"0001601485-21-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000033","line_url":"/filing/0001601485-21-000033#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":431.0,"shares_display":"431","price_per_share":11.01,"price_display":"11.01","price_state":"stated","total_value":4745.31,"total_display":"4,745.31","total_whole":"4,745","shares_owned_after":32589.0,"shares_owned_after_display":"32,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-15","scope":"insider"},{"id":5418776,"accession":"0001601485-21-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000027","line_url":"/filing/0001601485-21-000027#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":427.0,"shares_display":"427","price_per_share":13.27,"price_display":"13.27","price_state":"stated","total_value":5666.29,"total_display":"5,666.29","total_whole":"5,666","shares_owned_after":33020.0,"shares_owned_after_display":"33,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider"},{"id":5418772,"accession":"0001601485-21-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000023","line_url":"/filing/0001601485-21-000023#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":440.0,"shares_display":"440","price_per_share":13.92,"price_display":"13.92","price_state":"stated","total_value":6124.8,"total_display":"6,124.80","total_whole":"6,125","shares_owned_after":33447.0,"shares_owned_after_display":"33,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":5266116,"accession":"0001601485-21-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000011","line_url":"/filing/0001601485-21-000011#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399.0,"shares_display":"399","price_per_share":15.01,"price_display":"15.01","price_state":"stated","total_value":5988.99,"total_display":"5,988.99","total_whole":"5,989","shares_owned_after":33887.0,"shares_owned_after_display":"33,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-15","scope":"insider"},{"id":5437151,"accession":"0001567619-21-006400","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-006400","line_url":"/filing/0001567619-21-006400#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":499.0,"shares_display":"499","price_per_share":20.45,"price_display":"20.45","price_state":"stated","total_value":10204.55,"total_display":"10,204.55","total_whole":"10,205","shares_owned_after":34286.0,"shares_owned_after_display":"34,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-13","filed_date":"2021-03-16","scope":"insider"},{"id":5376795,"accession":"0001567619-21-004331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-004331","line_url":"/filing/0001567619-21-004331#line-1","is_derivative":false,"issuer_cik":"0001568249","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001568249","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":457.0,"shares_display":"457","price_per_share":19.54,"price_display":"19.54","price_state":"stated","total_value":8929.78,"total_display":"8,929.78","total_whole":"8,930","shares_owned_after":34785.0,"shares_owned_after_display":"34,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-13","filed_date":"2021-02-17","scope":"insider"},{"id":8392088,"accession":"0001209191-19-038602","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-038602","line_url":"/filing/0001209191-19-038602#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (CBO, GC & Compliance Officer)","role_mark":"O","role_mark_label":"Officer (CBO, GC & Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO, GC & Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":940.0,"shares_display":"940","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":5029.0,"total_display":"5,029.00","total_whole":"5,029","shares_owned_after":63114.0,"shares_owned_after_display":"63,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-20","filed_date":"2019-06-21","scope":"insider"},{"id":8513260,"accession":"0001209191-19-020769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-020769","line_url":"/filing/0001209191-19-020769#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (CBO, GC & Compliance Officer)","role_mark":"O","role_mark_label":"Officer (CBO, GC & Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO, GC & Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1792.0,"shares_display":"1,792","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":14318.08,"total_display":"14,318.08","total_whole":"14,318","shares_owned_after":31612.0,"shares_owned_after_display":"31,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-21","scope":"insider"},{"id":6524803,"accession":"0001209191-18-063937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-063937","line_url":"/filing/0001209191-18-063937#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (CBO, GC & Compliance Officer)","role_mark":"O","role_mark_label":"Officer (CBO, GC & Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO, GC & Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":425.0,"shares_display":"425","price_per_share":7.52,"price_display":"7.52","price_state":"stated","total_value":3196.0,"total_display":"3,196.00","total_whole":"3,196","shares_owned_after":33404.0,"shares_owned_after_display":"33,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2018-12-21","scope":"insider"},{"id":6633826,"accession":"0001209191-18-039257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-039257","line_url":"/filing/0001209191-18-039257#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (CBO, GC & Compliance Officer)","role_mark":"O","role_mark_label":"Officer (CBO, GC & Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO, GC & Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1002.0,"shares_display":"1,002","price_per_share":25.48,"price_display":"25.48","price_state":"stated","total_value":25530.96,"total_display":"25,530.96","total_whole":"25,531","shares_owned_after":33794.0,"shares_owned_after_display":"33,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-21","filed_date":"2018-06-22","scope":"insider"},{"id":6198883,"accession":"0001209191-18-021317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021317","line_url":"/filing/0001209191-18-021317#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (CBO, GC & Compliance Officer)","role_mark":"O","role_mark_label":"Officer (CBO, GC & Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO, GC & Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":982.0,"shares_display":"982","price_per_share":25.89,"price_display":"25.89","price_state":"stated","total_value":25423.98,"total_display":"25,423.98","total_whole":"25,424","shares_owned_after":34128.0,"shares_owned_after_display":"34,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-21","filed_date":"2018-03-22","scope":"insider"},{"id":4631848,"accession":"0001209191-17-066810","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-066810","line_url":"/filing/0001209191-17-066810#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (CBO, GC & Compliance Officer)","role_mark":"O","role_mark_label":"Officer (CBO, GC & Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO, GC & Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":440.0,"shares_display":"440","price_per_share":32.3,"price_display":"32.30","price_state":"stated","total_value":14212.0,"total_display":"14,212.00","total_whole":"14,212","shares_owned_after":28860.0,"shares_owned_after_display":"28,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-21","filed_date":"2017-12-21","scope":"insider"},{"id":4742697,"accession":"0001209191-17-041439","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-041439","line_url":"/filing/0001209191-17-041439#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (CBO, GC & Compliance Officer)","role_mark":"O","role_mark_label":"Officer (CBO, GC & Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO, GC & Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1041.0,"shares_display":"1,041","price_per_share":17.5348,"price_display":"17.53","price_state":"stated","total_value":18253.7268,"total_display":"18,253.73","total_whole":"18,254","shares_owned_after":28455.0,"shares_owned_after_display":"28,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-21","filed_date":"2017-06-22","scope":"insider"},{"id":8792871,"accession":"0001209191-15-027162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-027162","line_url":"/filing/0001209191-15-027162#line-1","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1390.0,"shares_display":"1,390","price_per_share":130.9201,"price_display":"130.92","price_state":"stated","total_value":181978.939,"total_display":"181,978.94","total_whole":"181,979","shares_owned_after":11090.0,"shares_owned_after_display":"11,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-17","scope":"insider"},{"id":8900364,"accession":"0001209191-15-020557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-020557","line_url":"/filing/0001209191-15-020557#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":122.0,"price_display":"122.00","price_state":"stated","total_value":244000.0,"total_display":"244,000.00","total_whole":"244,000","shares_owned_after":12480.0,"shares_owned_after_display":"12,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-02","scope":"insider"},{"id":8370627,"accession":"0001209191-15-019660","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-019660","line_url":"/filing/0001209191-15-019660","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3089.0,"shares_display":"3,089","price_per_share":119.29491744901263,"price_display":"119.29","price_state":"stated","total_value":368502.0,"total_display":"368,502.00","total_whole":"368,502","shares_owned_after":11391.0,"shares_owned_after_display":"11,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-26","filed_date":"2015-02-27","scope":"insider","n_lines":2},{"id":8486339,"accession":"0001209191-15-010532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-010532","line_url":"/filing/0001209191-15-010532#line-1","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":610.0,"shares_display":"610","price_per_share":100.8503,"price_display":"100.85","price_state":"stated","total_value":61518.683,"total_display":"61,518.68","total_whole":"61,519","shares_owned_after":8980.0,"shares_owned_after_display":"8,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"},{"id":6237134,"accession":"0001209191-14-073109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-073109","line_url":"/filing/0001209191-14-073109#line-1","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":910.0,"shares_display":"910","price_per_share":113.0,"price_display":"113.00","price_state":"stated","total_value":102830.0,"total_display":"102,830.00","total_whole":"102,830","shares_owned_after":9590.0,"shares_owned_after_display":"9,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-03","filed_date":"2014-12-04","scope":"insider"},{"id":6868262,"accession":"0001181431-14-003675","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-14-003675","line_url":"/filing/0001181431-14-003675","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001568249","owner_name":"Rhodes Jennifer J","owner_display_name":"Rhodes Jennifer J","owner_url":"/insider/0001568249","role":"Officer (GC & Chief Compliance Officer)","role_mark":"O","role_mark_label":"Officer (GC & Chief Compliance Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":76.28207142857143,"price_display":"76.28","price_state":"stated","total_value":1067949.0,"total_display":"1,067,949.00","total_whole":"1,067,949","shares_owned_after":10600.0,"shares_owned_after_display":"10,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-23","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP, CHIEF LEGAL OFFICER, SEC)","n_filings":2,"first_seen":"2026-02-10","last_seen":"2026-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001601485","name":"Angion Biomedica Corp.","url":"/issuer/0001601485","role":"Officer","n_filings":12,"first_seen":"2021-02-17","last_seen":"2021-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001328143","name":"Adamas Pharmaceuticals Inc","url":"/issuer/0001328143","role":"Officer (CBO, GC & Compliance Officer)","n_filings":7,"first_seen":"2017-06-22","last_seen":"2019-06-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001011835","name":"MEDIVATION, INC.","url":"/issuer/0001011835","role":"Officer (GC & Corporate Secretary)","n_filings":6,"first_seen":"2014-01-23","last_seen":"2015-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001568249","retrieved_at":"2026-08-24T12:41:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}